GENIUS GROUP LTD (GNS) Stock Fundamental Analysis

NYSEARCA:GNS • SGXZ81555062

0.4 USD
+0.01 (+2.54%)
At close: Feb 20, 2026
0.3904 USD
-0.01 (-2.4%)
After Hours: 2/20/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

GNS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 75 industry peers in the Diversified Consumer Services industry. GNS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GNS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year GNS has reported negative net income.
  • GNS had a negative operating cash flow in the past year.
  • GNS had negative earnings in each of the past 5 years.
  • GNS had a negative operating cash flow in each of the past 5 years.
GNS Yearly Net Income VS EBIT VS OCF VS FCFGNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • GNS has a worse Return On Assets (-29.26%) than 74.67% of its industry peers.
  • GNS has a worse Return On Equity (-39.98%) than 65.33% of its industry peers.
Industry RankSector Rank
ROA -29.26%
ROE -39.98%
ROIC N/A
ROA(3y)-32.95%
ROA(5y)-28.35%
ROE(3y)-284.46%
ROE(5y)-202.75%
ROIC(3y)N/A
ROIC(5y)N/A
GNS Yearly ROA, ROE, ROICGNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

  • The Gross Margin of GNS (32.64%) is worse than 62.67% of its industry peers.
  • GNS's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for GNS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-7.99%
GNS Yearly Profit, Operating, Gross MarginsGNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • GNS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, GNS has more shares outstanding
  • GNS has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for GNS has been reduced compared to a year ago.
GNS Yearly Shares OutstandingGNS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
GNS Yearly Total Debt VS Total AssetsGNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • GNS has an Altman-Z score of -1.46. This is a bad value and indicates that GNS is not financially healthy and even has some risk of bankruptcy.
  • GNS's Altman-Z score of -1.46 is on the low side compared to the rest of the industry. GNS is outperformed by 69.33% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that GNS is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.08, GNS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z -1.46
ROIC/WACCN/A
WACC9.07%
GNS Yearly LT Debt VS Equity VS FCFGNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • GNS has a Current Ratio of 2.16. This indicates that GNS is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.16, GNS is in the better half of the industry, outperforming 78.67% of the companies in the same industry.
  • GNS has a Quick Ratio of 2.12. This indicates that GNS is financially healthy and has no problem in meeting its short term obligations.
  • GNS has a better Quick ratio (2.12) than 78.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 2.12
GNS Yearly Current Assets VS Current LiabilitesGNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for GNS have decreased strongly by -13.33% in the last year.
  • The Revenue for GNS has decreased by -65.69% in the past year. This is quite bad
  • The Revenue has been decreasing by -4.48% on average over the past years.
EPS 1Y (TTM)-13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.34%
Revenue 1Y (TTM)-65.69%
Revenue growth 3Y-1.56%
Revenue growth 5Y-4.48%
Sales Q2Q%-44.32%

3.2 Future

  • Based on estimates for the next years, GNS will show a very strong growth in Earnings Per Share. The EPS will grow by 38.21% on average per year.
  • Based on estimates for the next years, GNS will show a very strong growth in Revenue. The Revenue will grow by 22.53% on average per year.
EPS Next Y62.92%
EPS Next 2Y38.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-19.23%
Revenue Next 2Y22.53%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GNS Yearly Revenue VS EstimatesGNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
GNS Yearly EPS VS EstimatesGNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • GNS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GNS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNS Price Earnings VS Forward Price EarningsGNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNS Per share dataGNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

  • GNS's earnings are expected to grow with 38.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.21%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • GNS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GENIUS GROUP LTD

NYSEARCA:GNS (2/20/2026, 8:04:00 PM)

After market: 0.3904 -0.01 (-2.4%)

0.4

+0.01 (+2.54%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)09-23
Earnings (Next)N/A
Inst Owners1.19%
Inst Owner Change-10.36%
Ins Owners8.57%
Ins Owner ChangeN/A
Market Cap35.12M
Revenue(TTM)7.91M
Net Income(TTM)-24.88M
AnalystsN/A
Price Target3.47 (767.5%)
Short Float %4.39%
Short Ratio3.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.44
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 0.82
EV/EBITDA N/A
EPS(TTM)-1.03
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0.09
BVpS0.71
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -29.26%
ROE -39.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.64%
FCFM N/A
ROA(3y)-32.95%
ROA(5y)-28.35%
ROE(3y)-284.46%
ROE(5y)-202.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.61%
GM growth 5Y-7.99%
F-Score0
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 338.28%
Cap/Sales 88.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.16
Quick Ratio 2.12
Altman-Z -1.46
F-Score0
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)138.36%
Cap/Depr(5y)102.77%
Cap/Sales(3y)32.99%
Cap/Sales(5y)23.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.34%
EPS Next Y62.92%
EPS Next 2Y38.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-65.69%
Revenue growth 3Y-1.56%
Revenue growth 5Y-4.48%
Sales Q2Q%-44.32%
Revenue Next Year-19.23%
Revenue Next 2Y22.53%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.95%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-311.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-273.5%
OCF growth 3YN/A
OCF growth 5YN/A

GENIUS GROUP LTD / GNS FAQ

What is the fundamental rating for GNS stock?

ChartMill assigns a fundamental rating of 2 / 10 to GNS.


What is the valuation status for GNS stock?

ChartMill assigns a valuation rating of 1 / 10 to GENIUS GROUP LTD (GNS). This can be considered as Overvalued.


How profitable is GENIUS GROUP LTD (GNS) stock?

GENIUS GROUP LTD (GNS) has a profitability rating of 0 / 10.


Can you provide the financial health for GNS stock?

The financial health rating of GENIUS GROUP LTD (GNS) is 4 / 10.